Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
Status:
Not yet recruiting
Trial end date:
2023-01-20
Target enrollment:
Participant gender:
Summary
This is a single center, open-label study to investigate whether HEC74647 and HEC110114 has
an effect on the pharmacokinetic (PK) profile of midazolam（a cytochrome (CYP) 3A4
substrate）in healthy subjects